
Heather Yu analyzed the 2014-15 Shigella outbreak and its relevance to discussions in drug resistance. Shigella is a common bacterial infection that affects about 450,000 people annually in the US. Out of the infected population, 17% are drug resistant. The risk associated with multi-drug resistant (MDR) Shigella can not be underestimated, as 6% of all strains are resistant to ciprofloxacin, the most common treatment method for the disease.
Continue reading “Heather Yu’s Case Study on Shigella in the United States”








